These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 7313358)

  • 1. [Antiarrhythmic actions of disopyramide phosphate in patients with paroxysmal supraventricular tachycardia (author's transl)].
    Satoh M; Sada T; Kuan-Min S; Kira Y; Sekine I; Okabe F; Ueda A; Ito T; Matsumoto S
    Kokyu To Junkan; 1981 May; 29(5):537-44. PubMed ID: 7313358
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention and therapy of supraventricular paroxysmal tachycardia in ambulatory patients. Results of a multicentric study using disopyramide].
    Rouhi A; Penth B; Adams HJ
    Ther Ggw; 1979 Jun; 118(6):957-69. PubMed ID: 462395
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of intravenous disopyramide in supraventricular paroxysmal tachycardia refractory to vagal maneuvers].
    Romero-Ayala LC; Soní J
    Arch Inst Cardiol Mex; 1983; 53(2):147-51. PubMed ID: 6882095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical studies of the antiarrhythmic efficacy of disopyramide phosphate (Norpace) (author's transl)].
    Smith WS
    Herz; 1978 Dec; 63(36):399-406. PubMed ID: 95482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of disopyramide phosphate in repetitive paroxysmal ventricular tachycardia].
    Katoh T; Sasaki Y; Tsuda T
    Kokyu To Junkan; 1982 Sep; 30(9):959-64. PubMed ID: 7178700
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical evaluation of Rhytmodan in heart rhythm disorders].
    Dzieglielewski T; Wachowiak A
    Pol Tyg Lek; 1973 Dec; 28(52):2065-7. PubMed ID: 4769022
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effectiveness and mechanism of the anti-arrhythmic action of ritmilen in patients with paroxysms of atrioventricular node reciprocal tachycardia].
    Grosu AA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1984; 7(2):98-9. PubMed ID: 6508939
    [No Abstract]   [Full Text] [Related]  

  • 8. [The prospective evolution of the efficacy of antiarrhythmia therapy in paroxysmal supraventricular tachycardia in patients with the ventricular pre-excitation syndrome].
    Fomina IG; Iankin VV
    Klin Med (Mosk); 1992 Jan; 70(1):26-32. PubMed ID: 1608203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Oral longterm therapy with disopyramide phosphate in patients with atrial and ventricular arrhythmias (author's transl)].
    Stauch M; Grewe N
    MMW Munch Med Wochenschr; 1977 Dec; 119(48):1563-6. PubMed ID: 74799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antiarrhythmic efficacy of intravenous therapy with disopyramide phosphate.
    Deano DA; Wu D; Mautner RK; Sherman RH; Ehsani AI; Rosen KM
    Chest; 1977 May; 71(5):597-606. PubMed ID: 856558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of intravenous disopyramide on induction and termination of paroxysmal supraventricular tachycardia via an accessory pathway].
    Komatsu C; Ishinaga T; Tateishi O; Tokuhisa Y; Hara M; Sanada T; Kanae K; Satoh Y; Yoshimura S
    Kokyu To Junkan; 1984 Apr; 32(4):409-14. PubMed ID: 6463419
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the clinical trial of disopyramide (Rhythmodan) in the prevention of attacks of supraventricular paroxysmal tachycardia].
    Masini G
    Minerva Med; 1970 Sep; 61(71 Suppl):3748-52. PubMed ID: 5454440
    [No Abstract]   [Full Text] [Related]  

  • 13. [Remote results of the treatment of rhythm disturbances with disopyramide].
    Desruelles J; Gerard A
    Arch Mal Coeur Vaiss; 1970 Feb; 63(2):182-9. PubMed ID: 4191762
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effect of disopyramide phosphate in extrasystole at rest and on exercise (author's transl)].
    Stauch M; Grewe N; Nissen H
    MMW Munch Med Wochenschr; 1976 Mar; 118(11):331-4. PubMed ID: 57570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of the association of acetyldigitoxin and disopyramide in the attack treatment of complete tachyarrhythmia due to auricular fibrillation].
    Lambert B
    Mars Med; 1971; 108(12):851-3. PubMed ID: 5145502
    [No Abstract]   [Full Text] [Related]  

  • 16. [Induction and termination of ventricular tachycardia by programmed electrical stimulation of heart--a case in which the effect of disopyramide phosphate was confirmed by the stimulation study (author's transl)].
    Komatsu C; Ishinaga T; Motoyama M; Marutani K; Teruya H; Nakayama M; Kuno A; Sato Y; Yoshimura S
    Kokyu To Junkan; 1981 Feb; 29(2):209-15. PubMed ID: 6789431
    [No Abstract]   [Full Text] [Related]  

  • 17. Disopyramide.
    Koch-Weser J
    N Engl J Med; 1979 Apr; 300(17):957-62. PubMed ID: 431563
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical evaluation of antiarrhythmic effects of disopyramide by multiclinical controlled double-blind methods.
    Kimura E; Mashima S; Tanaka T
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(8):338-43. PubMed ID: 7409935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of ventricular tachyarrhythmia with disopyramid phosphate].
    Steinbrunn W; Mattmann H; Enrico JF; Engel U
    Schweiz Med Wochenschr; 1980 Jun; 110(24):953-7. PubMed ID: 7414314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficiency of antiarrhythmic drugs of class 1C and isoptin in paroxysmal supraventricular tachycardia].
    Koshumbaeva KM; Tulenov MT; Belokopit IN
    Klin Med (Mosk); 2002; 80(2):57-60. PubMed ID: 11898726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.